Nestlé Enters Exclusive Talks to Sell Skin-Health Business--2nd Update
May 16 2019 - 3:59AM
Dow Jones News
By Brian Blackstone
ZURICH -- Nestle SA has entered exclusive talks to sell it
skin-health business to private-equity firm EQT and the Abu Dhabi
Investment Authority for 10.2 billion Swiss francs ($10.1 billion),
its latest move to reshape its sprawling portfolio and revive
sluggish growth.
The Swiss consumer goods giant said in September it was
exploring options for the unit as part of a broader effort by Chief
Executive Mark Schneider to reinvigorate Nestlé's portfolio and
focus more on coffee, pet care and consumer health.
Nestle said Thursday it expected to close the sale of the
skin-health business, which includes face-care products Cetaphil
and Proactiv, in the second half of the year, at which point it
would update investors on what it planned to do with the proceeds
and its future capital structure.
The division generated net sales of 2.8 billion Swiss francs in
2018.
Analysts at Vontobel Research said the price tag was at the high
end of its estimates. "In our model, we carried a price of 7
billion Swiss francs. However, we didn't rule out a price tag of up
to 10 billion Swiss francs," they said,
Nestlé established its skin-health unit in 2014 after taking
full control of Galderma, which added acne and skin-cancer
treatment to its portfolio. Nestlé said at the time it wanted to
take a more holistic approach to health than "mere nutrition" and
bolstered the unit with several acquisitions including a $1.4
billion deal for skin-care products from Valeant Pharmaceuticals
Inc. But as sales growth slowed, investors questioned how the unit
fits into Nestlé's broader business.
Thursday's step underscored Nestlé's prodding approach to
revamping its product mix that includes Purina pet food and Lean
Cuisine frozen meals and generates annual sales of around 91
billion Swiss francs. Faced with pressure from activist investors
two years ago, Nestle said it would focus its capital spending on
high-growth areas such coffee, pet care, and infant nutrition in a
bid to combat sluggish sales in a fast-changing consumer
environment.
Its approach has paid off. Last month, Nestle reported annual
comparable sales growth of 3.4%, topping analyst expectations. Its
share price is up 28% in the last year. Nestle shares were little
changed in early trading Thursday.
Last year, Nestlé sold its Gerber Life Insurance unit to Western
& Southern Financial Group for $1.55 billion in cash. It also
sold its U.S. confectionery business -- which includes Butterfinger
and Baby Ruth candy bars -- to Italian candy-maker Ferrero
International SA for $2.8 billion in cash.
Meanwhile, it has beefed up its coffee business. One year ago it
bought the rights to market and sell Starbucks coffee and tea
products in grocery and retail stores for more than $7 billion. In
2017, Nestlé bought a majority stake in U.S. premium coffee chain
Blue Bottle.
In late 2017 it bought Canadian vitamin maker Atrium Innovations
Inc., for $2.3 billion.
"Nestlé is well on track in successfully reshuffling its
portfolio, " the Vontobel analysts said.
--Anthony Shevlin in Barcelona contributed to this article.
Write to Brian Blackstone at brian.blackstone@wsj.com
(END) Dow Jones Newswires
May 16, 2019 03:44 ET (07:44 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Nestle (PK) (USOTC:NSRGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nestle (PK) (USOTC:NSRGY)
Historical Stock Chart
From Apr 2023 to Apr 2024